【作者】 朱萍；

【导师】 孙元欣；

【作者基本信息】 上海财经大学 ， 工商管理（专业学位）， 2020， 硕士

【摘要】 随着经济全球化,市场竞争的激烈程度不断增强,企业竞争早已从单一的产品质量或者价格竞争,变革成综合实力的竞争,是单一竞争到多元竞争的转变,是从产品层面的竞争到管理模式的竞争。目中国目前已经成为仅次于美国的全球第二大的医药市场,尽管外需相对疲弱,但内需强劲,占全球医药产业总产值的比例约为11%,医药总产值从2007年的6719亿元增长到2017年的35699亿元,10年的年复合增长率约为18.2%。医药行业是技术密集和研发驱动型行业,前景广阔,是一片亟待开发的蓝海。到2019年底,中国医药制造企业近8000家,市场竞争极其激烈。因此医药企业只有不断提高其核心竞争力和综合实力,才能在激烈竞争中脱颖而出。绩效管理是当前企业通行用以提升绩效的管理模式,只有做到个人及组织绩效的不断提升,才能带动企业整体的提升,最终实现企业的战略目标。所以建立科学且高效的绩效管理体系,并通过实践对其不断优化和改进,对企业的长期可持续发展起着至关重要的作用。本文的研究方法,主要采用文献查阅法、高层深度访谈法、问卷调查法和案例分析法。首先通过检索、阅读和分析大量相关文献,充分了解国内外和相关医药企业绩效管理的研究现状和实践经验。通过分析A企业的运营管理情况和人员结构,目前采用的绩效管理体系,用调查问卷对A企业核心员工进行调研,与老板(创始人)的深度访谈与对话,深入了解A企业绩效管理的问题并分析其原因。根据股东层制定的战略目标(每年净利润增加50%以上,加强自主创新能力,提升公司品牌和核心竞争力,实现可持续发展),2019年初领导团队,通过六步法,对已有的绩效管理方案进行优化,构建并实施了符合A企业发展需求的绩效管理方案,促进个人及组织绩效的整体提升,提高企业运营效率,降低成本,当年即完成净利润增加50%以上的目标。本文分为五章:第一章主要介绍了研究背景和目的,研究的意义、内容和方法。第二章是文献综述,首先阐述了绩效管理的定义和作用,通过文献综述介绍了国内外和相关医药企业采用的绩效管理方案,最后通过绩效管理演进大趋势,介绍了绩效管理的四个时期及使用的绩效管理方案。第三章介绍A医药企业的基本概况、所处行业、核心竞争力和劣势、目前采用的绩效管理体系。通过问卷调查法和高层深入访谈法,对A企业经营管理现状及绩效管理问题进行深入分析。第四章是主体部分,通过六步法,优化已有的绩效管理方案,具体阐述每一步的意义和具体实施方法,并通过绩效管理优化前后的相关经营管理指标结果来进行评价和分析。第五章是总结与展望,总结本文的研究成果、创新性以及不足,希望在将来的工作实践中可以进一步优化和提升。本文的主要研究成果包括以下三点:一、通过高层访谈法和问卷调研法,找出A医药企业绩效管理存在的问题,分析并总结其成因。二、通过分析A医药企业内外部环境,分析现有绩效管理体系的问题,领导团队通过六步绩效管理方案,优化并完善既有的绩效管理方案,具体实施,即战略选择及运营目标设定、设定关键部门目标、建立绩效考核方案、重建薪酬体系、绩效辅导、评估绩效实施效果和再优化,最终提高A企业的绩效。三、通过具体阐述每个关键绩效指标设置目的和意义,对同类型医药企业起到很好的参考作用,具有很强的实践作用。本文的创新性体现在理论分析与实证研究的基础上,结合MBA专业课程的学习,以及在公司管理和运营的实践,通过分析中小型民营医药企业的绩效管理问题,从而通过绩效管理六步法优化已有的绩效管理体系,并重建薪酬体系,通过绩效管理的实践和评估,再进一步优化。绩效管理方案里分析了关键绩效指标设置的意义并对其量化考核,对同类型的企业可以起到实质性的参考作用,有很强的操作性和实践意义。更多还原

【Abstract】 With the rapid development of economy,the market competition is increasing.Enterprise’s competition has already changed from single product quality or price competition to comprehensive strength competition.It is the transformation from single competition to multiple competition,from the competition of product to management mode.At present,China is the world’s largest emerging market in the pharmaceutical industry.The total output value of modern pharmaceutical industry has rapidly increased from 671.9billion yuan in 2007 to 3569.9 billion yuan in 2017.The annual output value growth rate is about 18.2%,accounting for about 11% of the global pharmaceutical market.China has become the second largest pharmaceutical market in the world only ranking after the United States.The pharmaceutical industry is a technology intensive and R & D driven industry with broad prospects and a blue ocean to be developed.By the end of 2019,there are nearly 8000 pharmaceutical manufacturing enterprises in China,and the market competition is extremely fierce.Therefore,only by continuously improving its core competitiveness and comprehensive strength can pharmaceutical enterprises stand out in the fierce competition.Performance management is the current management mode of enterprises.Only by continuously improving the performance of individuals and organizations can we promote the overall improvement of enterprises and ultimately achieve the strategic objectives of enterprises.Therefore,the establishment of a scientific and efficient performance management scheme with continuous optimization and improvement through practice,plays a vital role in the long-term sustainable development of enterprises.In terms of research methods,based on the relevant theories of performance management,literature review,high-level in-depth interview,questionnaire survey and case analysis are used.Through the relevant literature retrieval and analysis,to learn the research status and practical experience regarding performance management of domestic and foreign pharmaceutical enterprises.Through the analysis of the management situation and personnel structure of enterprise A,investigation by questionnaire among core employees,and the in-depth interview and dialogue with the boss(founder),the problems of performance management of A enterprise were found and the reasons were analyzed.Based on the strategic objectives set by the shareholders(increase net profit by more than 50% per year,strengthen the ability of independent innovation,enhance the company’s brand and core competitiveness,and realize sustainable development).In 2019,through the six steps’ method,the existing performance management scheme was optimized and carried out,the overall improvement of individual and organizational performance was improved,,so as to achieve the goal of increasing the net profit by more than 50% in 2019.There are five main chapters.The first chapter introduces the background,significance,content and methods of the study.The second chapter is literature review.Firstly,it introduces the definition and function of performance management,and then introduces the performance management schemes adopted by domestic and foreign pharmaceutical enterprises.Finally,through the evolution trend of performance management,it introduces the four periods of performance management and the performance management schemes used.The third chapter introduces the basic situation,industry analysis,core competitiveness and weakness of A pharmaceutical enterprise.Through questionnaire survey and high-level in-depth interview,the paper summarizes the performance management problems of A pharmaceutical enterprise and analyzes the reasons.The fourth chapter is the main part,through the six steps,to optimize the existing performance management scheme,specifically describes the significance of each step and specific implementation methods,and through the performance management optimization before and after the relevant index results to evaluate and analyze.The fifth chapter is the summary and prospect of the research results,innovation and shortcomings of this paper.Further optimization and improvement in the future work practice is still necessary.The paper includes the following three main achievements:1.Through high-level interview and questionnaire survey,this paper summarizes the performance management problems of A pharmaceutical enterprise and analyzes the reasons.2.Based on the situation of A pharmaceutical enterprise,the existing performance management plan is optimizes and implemented through six steps’ performance management scheme,namely,strategic selection and operation target setting,setting key department objectives,establishing performance evaluation scheme,rebuilding salary system,performance guidance,evaluating performance implementation effect and re-optimization,so as to ultimately improve the performance of A enterprise.3.Through the specific description of the purpose and significance of each key performance indicator,it plays a good reference role for the same type of pharmaceutical enterprises,and has a strong practical role.Through the combination of theoretical analysis and practice of enterprise management,this paper detailed analyzed the performance management problems exited in small and medium-sized private pharmaceutical enterprises,the six-steps’ optimization of the existing performance management system,and reconstruction of the salary system,and the practice and evaluation of performance management,further optimization.In the performance management scheme,the significance of setting key performance indicators is analyzed and quantified.It plays a substantive reference role for the same type of enterprises,and has strong operational and practical significance.更多还原